Health3 years ago
CoVac-1 has promising results in patients with cancer-related immunoglobulin deficiency
CoVac-1, a multipeptide COVID-19 vaccine, American Association for Cancer Research (AACR) 2022 Annual Meeting.. Researchers have considered using peptide-based T cell activators to induce a T...
Recent Comments